Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial.

El-Khateeb, Eman; El-Berri, Eman I; Mosalam, Esraa M; Nooh, Mohamed Z; Abdelsattar, Shimaa; Alghamdi, Amira M; Alrubia, Sarah; Abdallah, Mahmoud S

El-Khateeb, Eman; El-Berri, Eman I; Mosalam, Esraa M; Nooh, Mohamed Z; Abdelsattar, Shimaa; Alghamdi, Amira M; Alrubia, Sarah; Abdallah, Mahmoud S.

Afiliación

El-Khateeb E; Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt.
El-Berri EI; Certara UK Limited (Simcyp Division), Sheffield, United Kingdom.
Mosalam EM; Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt.
Nooh MZ; Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebin ElKoum, Egypt.
Abdelsattar S; Department of Internal Medicine, Faculty of Medicine, Menoufia University, Shebin ElKoum, Egypt.
Alghamdi AM; Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin ElKoum, Egypt.
Alrubia S; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Abdallah MS; Pharmaceutical Chemistry Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Front Pharmacol ; 14: 1153653, 2023.

Article en En | MEDLINE | ID: mdl-37113754

Palabras clave

T2DM; diabetes; leukotriene receptor antagonist; metformin; montelukast; obesity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google